Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$23.20M
28 trades · 5 insiders
Net · 90d
$-23.20M
Insiders on file
36
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Blum Robert I | President & CEO, Director | 569 | $0 | $69.95M | 2026-11-02 |
| Malik Fady Ibraham | SVP Research & Early Dev | 400 | $0 | $34.24M | 2026-10-20 |
| Harrington Robert Arthur | Director | 32 | $0 | $394.9K | 2026-10-16 |
| Daly James M | Director | 7 | $0 | $0 | 2026-10-16 |
| Kaye Edward M. MD | Director | 70 | $0 | $5.51M | 2026-10-16 |
| Wysenski Nancy | Director | 37 | $0 | $0 | 2026-10-16 |
| WIERENGA WENDELL | Director | 16 | $0 | $1.88M | 2026-10-16 |
| HENDERSON JOHN T | Director | 122 | $51.4K | $5.75M | 2026-10-16 |
| Landry Robert E | Director | 9 | $0 | $293.6K | 2026-09-15 |
| PARSHALL B LYNNE | Director | 101 | $0 | $9.04M | 2026-09-01 |
| Callos Andrew | EVP, Chief Commercial Officers | 112 | $0 | $20.80M | 2026-08-31 |
| Lee Sung | EVP, Chief Financial Officer | 47 | $0 | $5.70M | 2026-07-01 |
| Bhanji Muna | Director | 20 | $0 | $215.6K | 2026-05-27 |
| Hessekiel Jeffrey | Chief Legal & Admin Officer | 4 | $0 | $0 | 2026-03-15 |
| WIERENGA WENDALL | Director | 79 | $0 | $2.88M | 2025-07-15 |
| Wong Robert | VP, Chief Accounting Officer | 32 | $0 | $957.6K | 2024-12-03 |
| Pletcher Brett A | EVP, Chief Legal Officer | 2 | $0 | $0 | 2024-08-30 |
| COSTA SANTO J | Director | 52 | $0 | $3.00M | 2024-05-15 |
| SMITH SANDFORD D | Director | 150 | $0 | $6.69M | 2024-01-02 |
| Jaw Ching | SVP Finance & CFO | 61 | $0 | $4.99M | 2023-03-06 |
| SCHLOSSBERG MARK A | SVP - Legal & General Counsel | 32 | $0 | $2.05M | 2022-03-15 |
| Cragg David | SVP Human Resources | 80 | $0 | $3.80M | 2022-03-07 |
| Califf Robert | Director | 16 | $0 | $0 | 2022-01-03 |
| GAGE L PATRICK | Director | 80 | $174.0K | $2.05M | 2021-11-08 |
| Biotechnology Value Trading Fund OS LP | Other | 12 | $3.23M | $7.76M | 2020-12-09 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 3 | $0 | $16.93M | 2020-02-13 |
| McDowell Caryn Gordon | GC & Chief Compliance Officer | 110 | $0 | $574.5K | 2018-02-28 |
| RODDY PETER S | SVP Finance & CAO | 3 | $0 | $0 | 2018-02-27 |
| Morgan Bradley Paul | SVP Drug Discovery & Early Dev | 74 | $0 | $1.77M | 2017-08-31 |
| Schnieders Elisabeth | Sr. VP, Business Development | 5 | $0 | $0 | 2017-02-28 |
| CHARPENTIER BONNIE | SVP Regulatory & Compliance | 11 | $0 | $0 | 2017-02-28 |
| BARBARI SHARON SURREY | EVP, Finance & CFO | 18 | $0 | $0 | 2017-02-28 |
| WOLFF ANDREW A | SVP Clinical R&D, CMO | 27 | $0 | $170.6K | 2017-02-28 |
| GILBERT DENISE | Director | 5 | $0 | $0 | 2015-05-20 |
| DART KENNETH BRYAN | 10% Owner | 1 | $4.00M | $0 | 2014-02-25 |
| DOW STEPHEN M | Director | 4 | $0 | $1.06M | 2013-01-02 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Blum Robert I | President & CEO, Director | M Exercise deriv | 2026-11-02 | 2026-11-02 | 7,500 | — | $0 | 134,245 | SEC↗ |
| Blum Robert I | President & CEO, Director | S Sale | 2026-11-02 | 2026-11-02 | 7,500 | $62.81 | $471.1K | 278,544 | SEC↗ |
| Blum Robert I | President & CEO, Director | M Exercise | 2026-11-02 | 2026-11-02 | 7,500 | $10.60 | $79.5K | 286,044 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-10-20 | 2026-10-20 | 3,500 | — | $0 | 16,386 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-10-20 | 2026-10-20 | 3,500 | $64.01 | $224.0K | 153,902 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-10-20 | 2026-10-20 | 3,500 | $7.80 | $27.3K | 157,402 | SEC↗ |
| Wysenski Nancy | Director | A Award | 2026-10-16 | 2026-10-20 | 97 | $63.92 | $6.2K | 34,089 | SEC↗ |
| Kaye Edward M. MD | Director | A Award | 2026-10-16 | 2026-10-20 | 195 | $63.92 | $12.5K | 10,629 | SEC↗ |
| Harrington Robert Arthur | Director | A Award | 2026-10-16 | 2026-10-20 | 195 | $63.92 | $12.5K | 22,127 | SEC↗ |
| Daly James M | Director | A Award | 2026-10-16 | 2026-10-20 | 195 | $63.92 | $12.5K | 3,585 | SEC↗ |
| WIERENGA WENDELL | Director | A Award | 2026-10-16 | 2026-10-20 | 97 | $63.92 | $6.2K | 35,660 | SEC↗ |
| HENDERSON JOHN T | Director | A Award | 2026-10-16 | 2026-10-20 | 352 | $63.92 | $22.5K | 78,712 | SEC↗ |
| Blum Robert I | President & CEO, Director | M Exercise deriv | 2026-10-12 | 2026-10-13 | 7,500 | — | $0 | 141,745 | SEC↗ |
| Blum Robert I | President & CEO, Director | S Sale | 2026-10-12 | 2026-10-13 | 7,500 | $62.88 | $471.6K | 278,544 | SEC↗ |
| Blum Robert I | President & CEO, Director | M Exercise | 2026-10-12 | 2026-10-13 | 7,500 | $10.60 | $79.5K | 286,044 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-10-06 | 2026-10-06 | 3,500 | — | $0 | 19,886 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-10-06 | 2026-10-06 | 3,500 | $61.38 | $214.8K | 153,902 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-10-06 | 2026-10-06 | 3,500 | $7.80 | $27.3K | 157,402 | SEC↗ |
| Blum Robert I | President & CEO | M Exercise deriv | 2026-09-28 | 2026-09-28 | 7,500 | — | $0 | 149,245 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-09-28 | 2026-09-28 | 7,500 | $65.46 | $490.9K | 278,544 | SEC↗ |
| Blum Robert I | President & CEO | M Exercise | 2026-09-28 | 2026-09-28 | 7,500 | $10.60 | $79.5K | 286,044 | SEC↗ |
| Blum Robert I | President & CEO, Director | M Exercise deriv | 2026-09-28 | 2026-09-28 | 7,500 | — | $0 | 149,245 | SEC↗ |
| Blum Robert I | President & CEO, Director | S Sale | 2026-09-28 | 2026-09-28 | 7,500 | $65.46 | $490.9K | 278,544 | SEC↗ |
| Blum Robert I | President & CEO, Director | M Exercise | 2026-09-28 | 2026-09-28 | 7,500 | $10.60 | $79.5K | 286,044 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-09-22 | 2026-09-22 | 3,500 | — | $0 | 23,386 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-09-22 | 2026-09-22 | 3,500 | $68.29 | $239.0K | 153,902 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-09-22 | 2026-09-22 | 3,500 | $7.80 | $27.3K | 157,402 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-09-22 | 2026-09-22 | 3,500 | — | $0 | 23,386 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-09-22 | 2026-09-22 | 3,500 | $68.29 | $239.0K | 153,902 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-09-22 | 2026-09-22 | 3,500 | $7.80 | $27.3K | 157,402 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-09-15 | 2026-09-15 | 97,926 | $69.33 | $6.79M | 0 | SEC↗ |
| Landry Robert E | Director | S Sale | 2026-09-15 | 2026-09-15 | 1,000 | $72.13 | $72.1K | 8,184 | SEC↗ |
| Landry Robert E | Director | S Sale | 2026-09-15 | 2026-09-15 | 1,000 | $72.13 | $72.1K | 8,184 | SEC↗ |
| Blum Robert I | President & CEO, Director | S Sale | 2026-09-15 | 2026-09-15 | 97,926 | $69.33 | $6.79M | 0 | SEC↗ |
| Blum Robert I | President & CEO | M Exercise deriv | 2026-09-14 | 2026-09-15 | 7,500 | — | $0 | 156,745 | SEC↗ |
| Blum Robert I | President & CEO | G Gift | 2026-09-14 | 2026-09-15 | 97,926 | — | $0 | 97,926 | SEC↗ |
| Blum Robert I | President & CEO | G Gift | 2026-09-14 | 2026-09-15 | 97,926 | — | $0 | 278,544 | SEC↗ |
| Blum Robert I | President & CEO | G Gift | 2026-09-14 | 2026-09-15 | 1,350 | — | $0 | 376,470 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-09-14 | 2026-09-15 | 7,500 | $73.44 | $550.8K | 377,820 | SEC↗ |
| Blum Robert I | President & CEO | M Exercise | 2026-09-14 | 2026-09-15 | 7,500 | $10.60 | $79.5K | 385,320 | SEC↗ |
| Blum Robert I | President & CEO, Director | M Exercise deriv | 2026-09-14 | 2026-09-15 | 7,500 | — | $0 | 156,745 | SEC↗ |
| Blum Robert I | President & CEO, Director | G Gift | 2026-09-14 | 2026-09-15 | 97,926 | — | $0 | 97,926 | SEC↗ |
| Blum Robert I | President & CEO, Director | G Gift | 2026-09-14 | 2026-09-15 | 97,926 | — | $0 | 278,544 | SEC↗ |
| Blum Robert I | President & CEO, Director | G Gift | 2026-09-14 | 2026-09-15 | 1,350 | — | $0 | 376,470 | SEC↗ |
| Blum Robert I | President & CEO, Director | S Sale | 2026-09-14 | 2026-09-15 | 7,500 | $73.44 | $550.8K | 377,820 | SEC↗ |
| Blum Robert I | President & CEO, Director | M Exercise | 2026-09-14 | 2026-09-15 | 7,500 | $10.60 | $79.5K | 385,320 | SEC↗ |
| Landry Robert E | Director | S Sale | 2026-09-11 | 2026-09-11 | 1,000 | $74.66 | $74.7K | 9,184 | SEC↗ |
| Landry Robert E | Director | S Sale | 2026-09-11 | 2026-09-11 | 1,000 | $74.66 | $74.7K | 9,184 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-09-08 | 2026-09-08 | 3,500 | — | $0 | 26,886 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-09-08 | 2026-09-08 | 3,500 | $75.46 | $264.1K | 153,902 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-09-08 | 2026-09-08 | 3,500 | $7.80 | $27.3K | 157,402 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-09-08 | 2026-09-08 | 3,500 | — | $0 | 26,886 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-09-08 | 2026-09-08 | 3,500 | $75.46 | $264.1K | 153,902 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-09-08 | 2026-09-08 | 3,500 | $7.80 | $27.3K | 157,402 | SEC↗ |
| PARSHALL B LYNNE | Director | S Sale | 2026-09-01 | 2026-09-01 | 5,000 | $71.48 | $357.4K | 10,784 | SEC↗ |
| PARSHALL B LYNNE | Director | S Sale | 2026-09-01 | 2026-09-01 | 5,000 | $71.48 | $357.4K | 10,784 | SEC↗ |
| Blum Robert I | President & CEO | M Exercise deriv | 2026-08-31 | 2026-08-31 | 7,500 | — | $0 | 164,245 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2026-08-31 | 2026-08-31 | 10,000 | — | $0 | 0 | SEC↗ |
| Blum Robert I | President & CEO | M Exercise | 2026-08-31 | 2026-08-31 | 7,500 | $10.60 | $79.5K | 385,320 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-08-31 | 2026-08-31 | 7,500 | $70.24 | $526.8K | 377,820 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-08-31 | 2026-08-31 | 10,000 | $70.24 | $702.4K | 58,555 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2026-08-31 | 2026-08-31 | 10,000 | $23.26 | $232.6K | 68,555 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2026-08-31 | 2026-08-31 | 10,000 | — | $0 | 0 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-08-31 | 2026-08-31 | 10,000 | $70.24 | $702.4K | 58,555 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2026-08-31 | 2026-08-31 | 10,000 | $23.26 | $232.6K | 68,555 | SEC↗ |
| Blum Robert I | President & CEO, Director | M Exercise deriv | 2026-08-31 | 2026-08-31 | 7,500 | — | $0 | 164,245 | SEC↗ |
| Blum Robert I | President & CEO, Director | S Sale | 2026-08-31 | 2026-08-31 | 7,500 | $70.24 | $526.8K | 377,820 | SEC↗ |
| Blum Robert I | President & CEO, Director | M Exercise | 2026-08-31 | 2026-08-31 | 7,500 | $10.60 | $79.5K | 385,320 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-08-18 | 2026-08-18 | 3,500 | — | $0 | 30,386 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-08-18 | 2026-08-18 | 3,500 | $75.82 | $265.4K | 153,902 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-08-18 | 2026-08-18 | 3,500 | $7.80 | $27.3K | 157,402 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-08-18 | 2026-08-18 | 3,500 | — | $0 | 30,386 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-08-18 | 2026-08-18 | 3,500 | $75.82 | $265.4K | 153,902 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-08-18 | 2026-08-18 | 3,500 | $7.80 | $27.3K | 157,402 | SEC↗ |
| Blum Robert I | President & CEO | M Exercise deriv | 2026-08-10 | 2026-08-10 | 7,500 | — | $0 | 171,745 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-08-10 | 2026-08-10 | 7,500 | $76.76 | $575.7K | 377,820 | SEC↗ |
| Blum Robert I | President & CEO | M Exercise | 2026-08-10 | 2026-08-10 | 7,500 | $10.60 | $79.5K | 385,320 | SEC↗ |
| Blum Robert I | President & CEO, Director | M Exercise deriv | 2026-08-10 | 2026-08-10 | 7,500 | — | $0 | 171,745 | SEC↗ |
| Blum Robert I | President & CEO, Director | S Sale | 2026-08-10 | 2026-08-10 | 7,500 | $76.76 | $575.7K | 377,820 | SEC↗ |
| Blum Robert I | President & CEO, Director | M Exercise | 2026-08-10 | 2026-08-10 | 7,500 | $10.60 | $79.5K | 385,320 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2026-07-30 | 2026-07-30 | 14,000 | — | $0 | 10,000 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-07-30 | 2026-07-30 | 14,000 | $79.88 | $1.12M | 58,555 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2026-07-30 | 2026-07-30 | 14,000 | $23.26 | $325.6K | 72,555 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2026-07-30 | 2026-07-30 | 14,000 | — | $0 | 10,000 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-07-30 | 2026-07-30 | 14,000 | $79.88 | $1.12M | 58,555 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2026-07-30 | 2026-07-30 | 14,000 | $23.26 | $325.6K | 72,555 | SEC↗ |
| Blum Robert I | President & CEO | M Exercise deriv | 2026-07-27 | 2026-07-27 | 7,500 | — | $0 | 179,245 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-07-27 | 2026-07-27 | 7,500 | $80.87 | $606.5K | 377,820 | SEC↗ |
| Blum Robert I | President & CEO | M Exercise | 2026-07-27 | 2026-07-27 | 7,500 | $10.60 | $79.5K | 385,320 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-07-21 | 2026-07-23 | 3,500 | — | $0 | 33,886 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-07-21 | 2026-07-23 | 3,500 | $80.59 | $282.1K | 153,902 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-07-21 | 2026-07-23 | 3,500 | $7.80 | $27.3K | 157,402 | SEC↗ |
| Daly James M | Director | A Award | 2026-07-15 | 2026-07-16 | 151 | $82.62 | $12.5K | 3,390 | SEC↗ |
| Harrington Robert Arthur | Director | A Award | 2026-07-15 | 2026-07-16 | 151 | $82.62 | $12.5K | 21,932 | SEC↗ |
| HENDERSON JOHN T | Director | A Award | 2026-07-15 | 2026-07-16 | 272 | $82.62 | $22.5K | 78,360 | SEC↗ |
| Kaye Edward M. MD | Director | A Award | 2026-07-15 | 2026-07-16 | 151 | $82.62 | $12.5K | 10,434 | SEC↗ |
| WIERENGA WENDELL | Director | A Award | 2026-07-15 | 2026-07-16 | 75 | $82.62 | $6.2K | 35,563 | SEC↗ |
| Wysenski Nancy | Director | A Award | 2026-07-15 | 2026-07-16 | 75 | $82.62 | $6.2K | 33,992 | SEC↗ |
| Blum Robert I | President & CEO | M Exercise deriv | 2026-07-13 | 2026-07-14 | 7,490 | — | $0 | 186,745 | SEC↗ |
| Blum Robert I | President & CEO | M Exercise | 2026-07-13 | 2026-07-14 | 7,490 | $10.60 | $79.4K | 385,310 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-07-13 | 2026-07-14 | 7,490 | $82.02 | $614.3K | 377,820 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-07-13 | 2026-07-14 | 10 | $82.02 | $820 | 377,820 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-07-07 | 2026-07-07 | 3,500 | — | $0 | 37,386 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-07-07 | 2026-07-07 | 3,500 | $7.80 | $27.3K | 157,402 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-07-07 | 2026-07-07 | 3,500 | $86.62 | $303.2K | 153,902 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise deriv | 2026-07-01 | 2026-07-02 | 1,112 | — | $0 | 26,709 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2026-07-01 | 2026-07-02 | 15,000 | — | $0 | 24,000 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | S Sale | 2026-07-01 | 2026-07-02 | 1,112 | $87.79 | $97.6K | 63,221 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise | 2026-07-01 | 2026-07-02 | 1,112 | $48.51 | $53.9K | 64,333 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2026-07-01 | 2026-07-02 | 15,000 | $23.26 | $348.9K | 73,555 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-07-01 | 2026-07-02 | 15,000 | $85.80 | $1.29M | 58,555 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-07-01 | 2026-07-02 | 7,500 | $84.92 | $636.9K | 377,830 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise deriv | 2026-06-29 | 2026-06-29 | 823 | — | $0 | 39,681 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise deriv | 2026-06-29 | 2026-06-29 | 1,113 | — | $0 | 52,304 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise deriv | 2026-06-29 | 2026-06-29 | 188 | — | $0 | 8,640 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise deriv | 2026-06-29 | 2026-06-29 | 822 | — | $0 | 40,504 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise deriv | 2026-06-29 | 2026-06-29 | 188 | — | $0 | 8,828 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise | 2026-06-29 | 2026-06-29 | 1,113 | $48.51 | $54.0K | 65,344 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise | 2026-06-29 | 2026-06-29 | 823 | $44.36 | $36.5K | 66,355 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise | 2026-06-29 | 2026-06-29 | 188 | $44.36 | $8.3K | 65,532 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | S Sale | 2026-06-29 | 2026-06-29 | 3,134 | $85.00 | $266.4K | 63,221 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise | 2026-06-29 | 2026-06-29 | 822 | $44.36 | $36.5K | 64,231 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise | 2026-06-29 | 2026-06-29 | 188 | $44.36 | $8.3K | 63,409 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise deriv | 2026-06-24 | 2026-06-29 | 9,307 | — | $0 | 32,019 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise deriv | 2026-06-24 | 2026-06-29 | 23,370 | — | $0 | 30,047 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise deriv | 2026-06-24 | 2026-06-29 | 1,113 | — | $0 | 28,934 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise deriv | 2026-06-24 | 2026-06-29 | 188 | — | $0 | 6,011 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise deriv | 2026-06-24 | 2026-06-29 | 822 | — | $0 | 31,197 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise deriv | 2026-06-24 | 2026-06-29 | 2,817 | — | $0 | 6,199 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise deriv | 2026-06-24 | 2026-06-29 | 1,113 | — | $0 | 27,821 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise | 2026-06-24 | 2026-06-29 | 188 | $44.36 | $8.3K | 100,016 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise | 2026-06-24 | 2026-06-29 | 1,113 | $48.51 | $54.0K | 101,951 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise | 2026-06-24 | 2026-06-29 | 822 | $44.36 | $36.5K | 100,838 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise | 2026-06-24 | 2026-06-29 | 1,113 | $48.51 | $54.0K | 99,828 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | S Sale | 2026-06-24 | 2026-06-29 | 38,730 | $82.30 | $3.19M | 63,221 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise | 2026-06-24 | 2026-06-29 | 2,817 | $44.36 | $125.0K | 98,715 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise | 2026-06-24 | 2026-06-29 | 9,307 | $44.36 | $412.9K | 95,898 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | M Exercise | 2026-06-24 | 2026-06-29 | 23,370 | $48.51 | $1.13M | 86,591 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-06-23 | 2026-06-23 | 3,500 | — | $0 | 40,886 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-06-23 | 2026-06-23 | 3,500 | $7.80 | $27.3K | 157,402 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-06-23 | 2026-06-23 | 3,500 | $79.51 | $278.3K | 153,902 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-06-15 | 2026-06-15 | 7,500 | $70.46 | $528.5K | 385,330 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-06-09 | 2026-06-09 | 3,500 | — | $0 | 44,386 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-06-09 | 2026-06-09 | 3,500 | $67.98 | $237.9K | 153,902 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-06-09 | 2026-06-09 | 3,500 | $7.80 | $27.3K | 157,402 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2026-06-01 | 2026-06-01 | 15,000 | — | $0 | 39,000 | SEC↗ |
| PARSHALL B LYNNE | Director | S Sale | 2026-06-01 | 2026-06-01 | 5,000 | $74.08 | $370.4K | 15,784 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-06-01 | 2026-06-01 | 15,000 | $74.08 | $1.11M | 58,555 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2026-06-01 | 2026-06-01 | 15,000 | $23.26 | $348.9K | 73,555 | SEC↗ |
| Kaye Edward M. MD | Director | S Sale | 2026-06-01 | 2026-06-01 | 2,933 | $76.09 | $223.2K | 10,283 | SEC↗ |
| Wysenski Nancy | Director | A Award deriv | 2026-05-27 | 2026-05-27 | 4,301 | — | $0 | 4,301 | SEC↗ |
| WIERENGA WENDELL | Director | A Award deriv | 2026-05-27 | 2026-05-27 | 4,301 | — | $0 | 4,301 | SEC↗ |
| Landry Robert E | Director | A Award deriv | 2026-05-27 | 2026-05-27 | 4,301 | — | $0 | 4,301 | SEC↗ |
| PARSHALL B LYNNE | Director | A Award deriv | 2026-05-27 | 2026-05-27 | 4,301 | — | $0 | 4,301 | SEC↗ |
| Kaye Edward M. MD | Director | A Award deriv | 2026-05-27 | 2026-05-27 | 4,301 | — | $0 | 4,301 | SEC↗ |
| HENDERSON JOHN T | Director | A Award deriv | 2026-05-27 | 2026-05-27 | 4,301 | — | $0 | 4,301 | SEC↗ |
| Harrington Robert Arthur | Director | A Award deriv | 2026-05-27 | 2026-05-27 | 4,301 | — | $0 | 4,301 | SEC↗ |
| Daly James M | Director | A Award deriv | 2026-05-27 | 2026-05-27 | 4,301 | — | $0 | 4,301 | SEC↗ |
| Bhanji Muna | Director | A Award deriv | 2026-05-27 | 2026-05-27 | 4,301 | — | $0 | 4,301 | SEC↗ |
| Wysenski Nancy | Director | A Award | 2026-05-27 | 2026-05-27 | 2,851 | — | $0 | 33,917 | SEC↗ |
| WIERENGA WENDELL | Director | A Award | 2026-05-27 | 2026-05-27 | 2,851 | — | $0 | 35,488 | SEC↗ |
| Landry Robert E | Director | A Award | 2026-05-27 | 2026-05-27 | 2,851 | — | $0 | 10,184 | SEC↗ |
| PARSHALL B LYNNE | Director | A Award | 2026-05-27 | 2026-05-27 | 2,851 | — | $0 | 20,784 | SEC↗ |
| Kaye Edward M. MD | Director | A Award | 2026-05-27 | 2026-05-27 | 2,851 | — | $0 | 13,216 | SEC↗ |
| HENDERSON JOHN T | Director | A Award | 2026-05-27 | 2026-05-27 | 2,851 | — | $0 | 78,088 | SEC↗ |
| Harrington Robert Arthur | Director | A Award | 2026-05-27 | 2026-05-27 | 2,851 | — | $0 | 21,781 | SEC↗ |
| Daly James M | Director | A Award | 2026-05-27 | 2026-05-27 | 2,851 | — | $0 | 3,239 | SEC↗ |
| Bhanji Muna | Director | A Award | 2026-05-27 | 2026-05-27 | 2,851 | — | $0 | 26,361 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-05-27 | 2026-05-28 | 7,500 | $77.21 | $579.1K | 392,830 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-05-19 | 2026-05-20 | 3,500 | — | $0 | 47,886 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-05-19 | 2026-05-20 | 3,500 | $75.69 | $264.9K | 153,902 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-05-19 | 2026-05-20 | 3,500 | $7.80 | $27.3K | 157,402 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-05-14 | 2026-05-14 | 7,500 | $77.92 | $584.4K | 400,330 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2026-05-05 | 2026-05-05 | 11,333 | — | $0 | 13,070 | SEC↗ |
| HENDERSON JOHN T | Director | M Exercise deriv | 2026-05-05 | 2026-05-05 | 20,000 | — | $0 | 0 | SEC↗ |
| WIERENGA WENDELL | Director | M Exercise deriv | 2026-05-05 | 2026-05-05 | 4,032 | — | $0 | 0 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-05-05 | 2026-05-05 | 3,500 | — | $0 | 51,386 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-05-05 | 2026-05-05 | 11,333 | $77.25 | $875.5K | 58,555 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2026-05-05 | 2026-05-05 | 11,333 | $39.13 | $443.5K | 69,888 | SEC↗ |
| HENDERSON JOHN T | Director | M Exercise | 2026-05-05 | 2026-05-05 | 20,000 | $7.61 | $152.2K | 95,237 | SEC↗ |
| HENDERSON JOHN T | Director | S Sale | 2026-05-05 | 2026-05-05 | 20,000 | $75.97 | $1.52M | 75,237 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | S Sale | 2026-05-05 | 2026-05-05 | 23,906 | $76.87 | $1.84M | 63,221 | SEC↗ |
| WIERENGA WENDELL | Director | S Sale | 2026-05-05 | 2026-05-05 | 4,032 | $75.00 | $302.4K | 32,637 | SEC↗ |
| WIERENGA WENDELL | Director | M Exercise | 2026-05-05 | 2026-05-05 | 4,032 | $12.40 | $50.0K | 36,669 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-05-05 | 2026-05-05 | 3,500 | $77.37 | $270.8K | 153,902 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-05-05 | 2026-05-05 | 3,500 | $7.80 | $27.3K | 157,402 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2026-05-01 | 2026-05-04 | 15,857 | — | $0 | 0 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-05-01 | 2026-05-04 | 15,857 | $65.00 | $1.03M | 58,555 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2026-05-01 | 2026-05-04 | 15,857 | $37.63 | $596.7K | 74,412 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2026-04-30 | 2026-04-30 | 15,000 | — | $0 | 54,000 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-04-30 | 2026-04-30 | 15,000 | $63.26 | $948.9K | 58,555 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2026-04-30 | 2026-04-30 | 15,000 | $23.26 | $348.9K | 73,555 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-04-29 | 2026-04-29 | 7,500 | $59.62 | $447.1K | 407,830 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-04-21 | 2026-04-21 | 3,500 | — | $0 | 54,886 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-04-21 | 2026-04-21 | 3,500 | $7.80 | $27.3K | 157,402 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-04-21 | 2026-04-21 | 3,500 | $65.69 | $229.9K | 153,902 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-04-15 | 2026-04-15 | 7,500 | $65.38 | $490.3K | 415,330 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-04-15 | 2026-04-15 | 7,449 | $66.02 | $491.8K | 58,555 | SEC↗ |
| Daly James M | Director | A Award | 2026-04-15 | 2026-04-15 | 191 | $65.37 | $12.5K | 388 | SEC↗ |
| Harrington Robert Arthur | Director | A Award | 2026-04-15 | 2026-04-15 | 191 | $65.37 | $12.5K | 18,930 | SEC↗ |
| HENDERSON JOHN T | Director | A Award | 2026-04-15 | 2026-04-15 | 325 | $65.37 | $21.2K | 75,237 | SEC↗ |
| Kaye Edward M. MD | Director | A Award | 2026-04-15 | 2026-04-15 | 191 | $65.37 | $12.5K | 10,365 | SEC↗ |
| WIERENGA WENDELL | Director | A Award | 2026-04-15 | 2026-04-15 | 95 | $65.37 | $6.2K | 32,637 | SEC↗ |
| Wysenski Nancy | Director | A Award | 2026-04-15 | 2026-04-15 | 95 | $65.37 | $6.2K | 31,066 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-04-07 | 2026-04-08 | 3,500 | — | $0 | 58,386 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2026-04-07 | 2026-04-08 | 1,000 | — | $0 | 0 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-04-07 | 2026-04-08 | 3,500 | $65.21 | $228.2K | 153,902 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-04-07 | 2026-04-08 | 1,000 | $10.60 | $10.6K | 154,902 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-04-07 | 2026-04-08 | 1,000 | $64.75 | $64.8K | 153,902 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2026-04-07 | 2026-04-08 | 3,500 | $7.80 | $27.3K | 157,402 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-04-01 | 2026-04-01 | 7,500 | $66.63 | $499.7K | 422,830 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-03-31 | 2026-03-31 | 3,639 | $65.00 | $236.5K | 66,004 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-03-18 | 2026-03-18 | 1,930 | $62.07 | $119.8K | 78,185 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-03-17 | 2026-03-18 | 23,928 | $62.15 | $1.49M | 430,330 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-03-17 | 2026-03-18 | 12,673 | $62.15 | $787.6K | 454,258 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-03-17 | 2026-03-18 | 7,636 | $62.15 | $474.6K | 158,299 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-03-17 | 2026-03-18 | 4,397 | $62.15 | $273.3K | 153,902 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-03-17 | 2026-03-18 | 2,916 | $62.15 | $181.2K | 71,573 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-03-17 | 2026-03-18 | 5,626 | $62.15 | $349.7K | 74,489 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | S Sale | 2026-03-17 | 2026-03-18 | 4,935 | $62.15 | $306.7K | 87,127 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-03-16 | 2026-03-16 | 1,709 | $61.03 | $104.3K | 46,149 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | A Award deriv | 2026-03-15 | 2026-03-17 | 39,527 | — | $0 | 39,527 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | A Award deriv | 2026-03-15 | 2026-03-17 | 1,665 | — | $0 | 1,665 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | A Award deriv | 2026-03-15 | 2026-03-17 | 29,480 | — | $0 | 29,480 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | A Award deriv | 2026-03-15 | 2026-03-17 | 1,665 | — | $0 | 1,665 | SEC↗ |
| Hessekiel Jeffrey | Chief Legal & Admin Officer | A Award deriv | 2026-03-15 | 2026-03-17 | 22,820 | — | $0 | 22,820 | SEC↗ |
| Hessekiel Jeffrey | Chief Legal & Admin Officer | A Award deriv | 2026-03-15 | 2026-03-17 | 8,325 | — | $0 | 8,325 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | A Award deriv | 2026-03-15 | 2026-03-17 | 29,480 | — | $0 | 29,480 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | A Award deriv | 2026-03-15 | 2026-03-17 | 1,665 | — | $0 | 1,665 | SEC↗ |
| Blum Robert I | President & CEO | A Award deriv | 2026-03-15 | 2026-03-17 | 111,864 | — | $0 | 111,864 | SEC↗ |
| Blum Robert I | President & CEO | A Award deriv | 2026-03-15 | 2026-03-17 | 1,665 | — | $0 | 1,665 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | A Award | 2026-03-15 | 2026-03-17 | 27,306 | — | $0 | 165,935 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | A Award | 2026-03-15 | 2026-03-17 | 20,646 | — | $0 | 92,062 | SEC↗ |
| Hessekiel Jeffrey | Chief Legal & Admin Officer | A Award | 2026-03-15 | 2026-03-17 | 20,646 | — | $0 | 107,943 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | A Award | 2026-03-15 | 2026-03-17 | 20,646 | — | $0 | 68,504 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | A Award | 2026-03-15 | 2026-03-17 | 13,320 | — | $0 | 81,824 | SEC↗ |
| Blum Robert I | President & CEO | A Award | 2026-03-15 | 2026-03-17 | 75,258 | — | $0 | 466,931 | SEC↗ |
| Blum Robert I | President & CEO | S Sale | 2026-03-09 | 2026-03-10 | 7,931 | $60.72 | $481.6K | 391,673 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2026-03-09 | 2026-03-10 | 2,907 | $60.72 | $176.5K | 138,629 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-03-09 | 2026-03-10 | 2,582 | $60.72 | $156.8K | 47,858 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2026-03-05 | 2026-03-05 | 11,000 | — | $0 | 24,403 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2026-03-05 | 2026-03-05 | 15,000 | — | $0 | 69,000 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-03-05 | 2026-03-05 | 15,000 | $61.87 | $928.0K | 61,440 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2026-03-05 | 2026-03-05 | 11,000 | $39.13 | $430.4K | 76,440 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-03-05 | 2026-03-05 | 11,000 | $61.88 | $680.7K | 50,440 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2026-03-05 | 2026-03-05 | 15,000 | $23.26 | $348.9K | 65,440 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2026-03-02 | 2026-03-02 | 886 | — | $0 | 0 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2026-03-02 | 2026-03-02 | 886 | $37.63 | $33.3K | 51,326 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-03-02 | 2026-03-02 | 886 | $61.62 | $54.6K | 50,440 | SEC↗ |
| PARSHALL B LYNNE | Director | S Sale | 2026-03-02 | 2026-03-02 | 5,000 | $61.21 | $306.1K | 17,933 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2026-02-05 | 2026-02-05 | 15,000 | — | $0 | 84,000 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2026-02-05 | 2026-02-05 | 15,000 | $23.26 | $348.9K | 65,440 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-02-05 | 2026-02-05 | 15,000 | $61.93 | $929.0K | 50,440 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2026-02-02 | 2026-02-02 | 886 | — | $0 | 886 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-02-02 | 2026-02-02 | 886 | $62.10 | $55.0K | 50,440 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2026-02-02 | 2026-02-02 | 886 | $37.63 | $33.3K | 51,326 | SEC↗ |
| Harrington Robert Arthur | Director | A Award | 2026-01-15 | 2026-01-16 | 197 | $63.44 | $12.5K | 18,739 | SEC↗ |
| HENDERSON JOHN T | Director | A Award | 2026-01-15 | 2026-01-16 | 334 | $63.44 | $21.2K | 74,912 | SEC↗ |
| Kaye Edward M. MD | Director | A Award | 2026-01-15 | 2026-01-16 | 197 | $63.44 | $12.5K | 10,174 | SEC↗ |
| WIERENGA WENDELL | Director | A Award | 2026-01-15 | 2026-01-16 | 98 | $63.44 | $6.2K | 32,542 | SEC↗ |
| Wysenski Nancy | Director | A Award | 2026-01-15 | 2026-01-16 | 98 | $63.44 | $6.2K | 30,971 | SEC↗ |
| Daly James M | Director | A Award | 2026-01-15 | 2026-01-20 | 197 | $63.44 | $12.5K | 197 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2026-01-05 | 2026-01-05 | 15,000 | — | $0 | 99,000 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-01-05 | 2026-01-05 | 15,000 | $60.28 | $904.2K | 50,440 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2026-01-05 | 2026-01-05 | 15,000 | $23.26 | $348.9K | 65,440 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2026-01-02 | 2026-01-02 | 885 | — | $0 | 1,772 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2026-01-02 | 2026-01-02 | 885 | $37.63 | $33.3K | 51,325 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-01-02 | 2026-01-02 | 885 | $63.16 | $55.9K | 50,440 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2026-01-02 | 2026-01-02 | 913 | $62.09 | $56.7K | 50,440 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2025-12-29 | 2025-12-30 | 1,809 | $62.44 | $113.0K | 51,353 | SEC↗ |
| WIERENGA WENDELL | Director | M Exercise deriv | 2025-12-22 | 2025-12-23 | 20,000 | — | $0 | 0 | SEC↗ |
| Blum Robert I | President & CEO | M Exercise deriv | 2025-12-22 | 2025-12-23 | 54,727 | — | $0 | 0 | SEC↗ |
| Blum Robert I | President & CEO | M Exercise deriv | 2025-12-22 | 2025-12-23 | 16,506 | — | $0 | 0 | SEC↗ |
| WIERENGA WENDELL | Director | M Exercise | 2025-12-22 | 2025-12-23 | 20,000 | $7.61 | $152.2K | 52,444 | SEC↗ |
| WIERENGA WENDELL | Director | S Sale | 2025-12-22 | 2025-12-23 | 20,000 | $66.14 | $1.32M | 32,444 | SEC↗ |
| Blum Robert I | President & CEO | M Exercise | 2025-12-22 | 2025-12-23 | 16,506 | $6.67 | $110.1K | 391,009 | SEC↗ |
| Blum Robert I | President & CEO | M Exercise | 2025-12-22 | 2025-12-23 | 54,727 | $6.67 | $365.0K | 404,929 | SEC↗ |
| Blum Robert I | President & CEO | F Tax w/h | 2025-12-22 | 2025-12-23 | 30,426 | $68.18 | $2.07M | 374,503 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | F Tax w/h | 2025-12-22 | 2025-12-29 | 805 | $62.72 | $50.5K | 71,416 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | A Award | 2025-12-22 | 2025-12-29 | 2,152 | — | $0 | 72,221 | SEC↗ |
| Lee Sung | EVP, Chief Financial Officer | A Award | 2025-12-22 | 2025-12-29 | 2,152 | — | $0 | 70,069 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | A Award | 2025-12-22 | 2025-12-29 | 1,589 | — | $0 | 52,249 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | F Tax w/h | 2025-12-22 | 2025-12-29 | 675 | $62.72 | $42.3K | 53,162 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | A Award | 2025-12-22 | 2025-12-29 | 1,588 | — | $0 | 53,837 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | A Award | 2025-12-22 | 2025-12-29 | 2,000 | — | $0 | 142,552 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | A Award | 2025-12-22 | 2025-12-29 | 2,000 | — | $0 | 140,552 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | F Tax w/h | 2025-12-22 | 2025-12-29 | 1,016 | $62.72 | $63.7K | 141,536 | SEC↗ |
| Blum Robert I | President & CEO | A Award | 2025-12-22 | 2025-12-29 | 5,765 | — | $0 | 396,774 | SEC↗ |
| Blum Robert I | President & CEO | F Tax w/h | 2025-12-22 | 2025-12-29 | 2,935 | $62.72 | $184.1K | 399,604 | SEC↗ |
| Blum Robert I | President & CEO | A Award | 2025-12-22 | 2025-12-29 | 5,765 | — | $0 | 402,539 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise deriv | 2025-12-16 | 2025-12-16 | 2,200 | — | $0 | 0 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | S Sale | 2025-12-16 | 2025-12-16 | 2,200 | $61.24 | $134.7K | 138,552 | SEC↗ |
| Malik Fady Ibraham | EVP Research & Development | M Exercise | 2025-12-16 | 2025-12-16 | 2,200 | $10.60 | $23.3K | 140,752 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2025-12-08 | 2025-12-08 | 1,042 | — | $0 | 35,403 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise | 2025-12-08 | 2025-12-08 | 1,042 | $39.13 | $40.8K | 51,702 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | S Sale | 2025-12-08 | 2025-12-08 | 1,042 | $65.96 | $68.7K | 50,660 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2025-12-05 | 2025-12-05 | 11,000 | — | $0 | 36,445 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2025-12-05 | 2025-12-05 | 15,000 | — | $0 | 114,000 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2025-12-05 | 2025-12-05 | 10,628 | — | $0 | 2,657 | SEC↗ |
| Callos Andrew | EVP, Chief Commercial Office | M Exercise deriv | 2025-12-05 | 2025-12-05 | 15,858 | — | $0 | 15,857 | SEC↗ |